Results 221 to 230 of about 1,619,987 (346)

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

Exploring Medical Information Needs and Accessibility in Swedish Dental Care by Analysis of Documentation Workflows and Electronic Dental Records in Dalarna: Sociotechnical Qualitative Study.

JMIR Hum Factors
Rahim SH, Davoody N, Bonacina S.
europepmc   +1 more source

Enhancing the Diagnosis of Behçet's Disease Using Machine Learning: A Comparative Study on Clinical Data From Saudi Arabia. [PDF]

Int J Telemed Appl
Alalwany H, Alganmi N, Bawazir Y, Mustafa M, Abusamra H, Banjar H, Alhothali A, Albaradei S.   +7 more
europepmc   +1 more source

The Brief Case: Bacteremia and vertebral osteomyelitis due to Staphylococcus schleiferi [PDF]

, 2017
Burnham, Carey-Ann D, George, Ige A, Hamad, Yasir, Yarbrough, Melanie L   +3 more
core   +2 more sources

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors. [PDF]

Diagnostics (Basel)
Yen C, Epling JW, Rockwell M, Vaughn-Cooke M.   +3 more
europepmc   +1 more source

Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).

Clinical Infectious Diseases
J. M. Miller, M. Binnicker, Sheldon Campbell, Karen C. Carroll, Kimberle C. Chapin, Mark D. Gonzalez, Amanda Harrington, R. Jerris, S. Kehl, Sixto M. Leal, Robin Patel, B. Pritt, Sandra S Richter, Barbara Robinson-Dunn, James W Snyder, Sam R Telford, E. Theel, Richard B. Thomson, Melvin P. Weinstein, Joseph D Yao   +19 more
semanticscholar   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

YouTube, Bilibili, and TikTok serve as important stroke-relevant information sources: A cross-sectional study. [PDF]

Digit Health
Shu H, Zhu Y, Yan T, Zhang W, Huang Z, Liang M, Long Z, Lv F, Tu W.   +8 more
europepmc   +1 more source